WeightWatchers Moves Into the Ozempic Market With Telehealth Deal - WSJ

Why Weight Watchers is buying a company that prescribes popular obesity drugs - MarketWatch

Eva Vyas on LinkedIn: Join us at HLTH and learn more about WeightWatchers for Business CEO Sima…

The $76 Billion Diet Industry Asks: What to Do About Ozempic? - WSJ

Ozempic and a Protein Shake: Food Makers Prep Weight-Loss-Drug Side Dishes - WSJ

WeightWatchers Stock Soars After Telehealth Deal

Ozempic Boom Is an Opportunity for Health Insurers - WSJ

Oprah, Ozempic and Apologies: WeightWatchers' New Formula - WSJ

WeightWatchers CEO: Ozempic era will end 'diet culture

The Ozempic Craze Could Put These Companies on a Crash Diet - WSJ

The Disruptive Power of Weight Loss Drugs Is Being Felt Beyond Pharma - The New York Times

Ozempic: How the Diabetes Drug Works and Why It's Such a Big Deal for Weight Loss - WSJ

The $76 Billion Diet Industry Asks: What to Do About Ozempic? - WSJ

Health Startups Offer Diabetes Drugs Like Ozempic for Weight Loss With Little Oversight - WSJ